Guaifenesin 21130-0554
Product NDC
21130-0554- Manufacturer
- Safeway, Inc
- Dosage Form
- Tablet
- Route
- Oral
- Product Type
- Human Otc Drug
- Marketing Start
- June 30, 2023
- Listing Expires
- December 31, 2026
- Application
- ANDA213420
Active Ingredients
| Ingredient | Strength |
|---|---|
| Guaifenesin | 1200 mg/1 |
Drug Class
Expectorant [EPC]Decreased Respiratory Secretion Viscosity [PE]Expectorant [EPC]
Packaging Options(1)
14 TABLET in 1 BLISTER PACK (21130-554-27)